| The role of medicinal plants in the treatment of diabetes: a systematic review W Kooti, M Farokhipour, Z Asadzadeh, D Ashtary-Larky, M Asadi-Samani Electronic physician 8 (1), 1832, 2016 | 455 | 2016 |
| The paradox of Th17 cell functions in tumor immunity Z Asadzadeh, H Mohammadi, E Safarzadeh, M Hemmatzadeh, ... Cellular immunology 322, 15-25, 2017 | 212 | 2017 |
| Current approaches for combination therapy of cancer: the role of immunogenic cell death Z Asadzadeh, E Safarzadeh, S Safaei, A Baradaran, A Mohammadi, ... Cancers 12 (4), 1047, 2020 | 123 | 2020 |
| microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities Z Asadzadeh, B Mansoori, A Mohammadi, M Aghajani, ... Journal of cellular physiology 234 (7), 10002-10017, 2019 | 95 | 2019 |
| The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV N Hemmat, Z Asadzadeh, NK Ahangar, H Alemohammad, B Najafzadeh, ... Archives of Virology 166, 675-696, 2021 | 81 | 2021 |
| New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation M Aghajani, B Mansoori, A Mohammadi, Z Asadzadeh, B Baradaran Journal of cellular physiology 234 (12), 21642-21661, 2019 | 80 | 2019 |
| Cytotoxic T-lymphocyte antigen-4 in colorectal cancer: another therapeutic side of capecitabine A Derakhshani, S Hashemzadeh, Z Asadzadeh, MA Shadbad, ... Cancers 13 (10), 2414, 2021 | 66 | 2021 |
| miR‐142‐3p is a tumor suppressor that inhibits estrogen receptor expression in ER‐positive breast cancer B Mansoori, A Mohammadi, MF Gjerstorff, S Shirjang, Z Asadzadeh, ... Journal of cellular physiology 234 (9), 16043-16053, 2019 | 52 | 2019 |
| Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects S Makaremi, Z Asadzadeh, N Hemmat, A Baghbanzadeh, A Sgambato, ... Biomedicines 9 (9), 1075, 2021 | 51 | 2021 |
| The oncogenic potential of NANOG: An important cancer induction mediator B Najafzadeh, Z Asadzadeh, R Motafakker Azad, A Mokhtarzadeh, ... Journal of cellular physiology 236 (4), 2443-2458, 2021 | 50 | 2021 |
| Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy A Derakhshani, N Hemmat, Z Asadzadeh, M Ghaseminia, MA Shadbad, ... Journal of clinical medicine 10 (5), 1051, 2021 | 49 | 2021 |
| Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes? K Hajiasgharzadeh, S Sadigh‐Eteghad, B Mansoori, A Mokhtarzadeh, ... Journal of cellular physiology 234 (9), 14666-14679, 2019 | 48 | 2019 |
| The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer H Alemohammad, B Najafzadeh, Z Asadzadeh, A Baghbanzadeh, ... Biomedicine & Pharmacotherapy 146, 112516, 2022 | 45 | 2022 |
| The positive and negative immunoregulatory role of B7 family: promising novel targets in gastric cancer treatment N Bolandi, A Derakhshani, N Hemmat, A Baghbanzadeh, Z Asadzadeh, ... International Journal of Molecular Sciences 22 (19), 10719, 2021 | 45 | 2021 |
| HMGA2 and Bach‐1 cooperate to promote breast cancer cell malignancy B Mansoori, A Mohammadi, Z Asadzadeh, S Shirjang, M Minouei, ... Journal of Cellular Physiology 234 (10), 17714-17726, 2019 | 35 | 2019 |
| CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel M Aghajani, A Mokhtarzadeh, L Aghebati-Maleki, B Mansoori, ... Molecular biology reports 47, 3691-3703, 2020 | 26 | 2020 |
| The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy Z Asadzadeh, B Mansoori, A Mohammadi, T Kazemi, A Mokhtarzadeh, ... Biomedicine & Pharmacotherapy 137, 111364, 2021 | 25 | 2021 |
| Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development SH Kiaie, MJ Sanaei, M Heshmati, Z Asadzadeh, I Azimi, S Hadidi, ... Acta Pharmaceutica Sinica B 11 (5), 1083-1097, 2021 | 25 | 2021 |
| MicroRNAs and lncRNAs—a new layer of myeloid-derived suppressor cells regulation E Safarzadeh, Z Asadzadeh, S Safaei, A Hatefi, A Derakhshani, ... Frontiers in immunology 11, 572323, 2020 | 23 | 2020 |
| A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery MA Shadbad, Z Asadzadeh, A Derakhshani, N Hosseinkhani, ... Biomedicine & Pharmacotherapy 143, 112213, 2021 | 22 | 2021 |
behzad baradaranImmunology Research Center, Tabriz University of Medical SciencesПотвърден имейл адрес: tbzmed.ac.ir
